253 related articles for article (PubMed ID: 33217338)
1. Systematic Activity Maturation of a Single-Domain Antibody with Non-canonical Amino Acids through Chemical Mutagenesis.
Lindstedt PR; Aprile FA; Sormanni P; Rakoto R; Dobson CM; Bernardes GJL; Vendruscolo M
Cell Chem Biol; 2021 Jan; 28(1):70-77.e5. PubMed ID: 33217338
[TBL] [Abstract][Full Text] [Related]
2. A Chemical Mutagenesis Approach to Insert Post-translational Modifications in Aggregation-Prone Proteins.
Ge Y; Masoura A; Yang J; Aprile FA
ACS Chem Neurosci; 2022 Jun; 13(12):1714-1718. PubMed ID: 35609278
[TBL] [Abstract][Full Text] [Related]
3. Facile Installation of Post-translational Modifications on the Tau Protein via Chemical Mutagenesis.
Lindstedt PR; Taylor RJ; Bernardes GJL; Vendruscolo M
ACS Chem Neurosci; 2021 Feb; 12(3):557-561. PubMed ID: 33464820
[TBL] [Abstract][Full Text] [Related]
4. Mutations that replace aromatic side chains promote aggregation of the Alzheimer's Aβ peptide.
Armstrong AH; Chen J; McKoy AF; Hecht MH
Biochemistry; 2011 May; 50(19):4058-67. PubMed ID: 21513285
[TBL] [Abstract][Full Text] [Related]
5. Rational design of a conformation-specific antibody for the quantification of Aβ oligomers.
Aprile FA; Sormanni P; Podpolny M; Chhangur S; Needham LM; Ruggeri FS; Perni M; Limbocker R; Heller GT; Sneideris T; Scheidt T; Mannini B; Habchi J; Lee SF; Salinas PC; Knowles TPJ; Dobson CM; Vendruscolo M
Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13509-13518. PubMed ID: 32493749
[TBL] [Abstract][Full Text] [Related]
6. Rational design of potent domain antibody inhibitors of amyloid fibril assembly.
Ladiwala AR; Bhattacharya M; Perchiacca JM; Cao P; Raleigh DP; Abedini A; Schmidt AM; Varkey J; Langen R; Tessier PM
Proc Natl Acad Sci U S A; 2012 Dec; 109(49):19965-70. PubMed ID: 23161913
[TBL] [Abstract][Full Text] [Related]
7. Combining non-canonical amino acid mutagenesis and native chemical ligation for multiply modifying proteins: A case study of α-synuclein post-translational modifications.
Galesic A; Pan B; Ramirez J; Rhoades E; Pratt MR; Petersson EJ
Methods; 2023 Oct; 218():101-109. PubMed ID: 37549799
[TBL] [Abstract][Full Text] [Related]
8. Rationally Designed Antibodies as Research Tools to Study the Structure-Toxicity Relationship of Amyloid-β Oligomers.
Limbocker R; Mannini B; Cataldi R; Chhangur S; Wright AK; Kreiser RP; Albright JA; Chia S; Habchi J; Sormanni P; Kumita JR; Ruggeri FS; Dobson CM; Chiti F; Aprile FA; Vendruscolo M
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630615
[TBL] [Abstract][Full Text] [Related]
9. Selective targeting of primary and secondary nucleation pathways in Aβ42 aggregation using a rational antibody scanning method.
Aprile FA; Sormanni P; Perni M; Arosio P; Linse S; Knowles TPJ; Dobson CM; Vendruscolo M
Sci Adv; 2017 Jun; 3(6):e1700488. PubMed ID: 28691099
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser
van Ameijde J; Crespo R; Janson R; Juraszek J; Siregar B; Verveen H; Sprengers I; Nahar T; Hoozemans JJ; Steinbacher S; Willems R; Delbroek L; Borgers M; Dockx K; Van Kolen K; Mercken M; Pascual G; Koudstaal W; Apetri A
Acta Neuropathol Commun; 2018 Jul; 6(1):59. PubMed ID: 30001207
[TBL] [Abstract][Full Text] [Related]
11. Physicochemical improvement of rabbit derived single-domain antibodies by substitutions with amino acids conserved in camelid antibodies.
Shinozaki N; Hashimoto R; Noda M; Uchiyama S
J Biosci Bioeng; 2018 Jun; 125(6):654-661. PubMed ID: 29398547
[TBL] [Abstract][Full Text] [Related]
12. Selection, characterization, and thermal stabilization of llama single domain antibodies towards Ebola virus glycoprotein.
Liu JL; Shriver-Lake LC; Anderson GP; Zabetakis D; Goldman ER
Microb Cell Fact; 2017 Dec; 16(1):223. PubMed ID: 29233140
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
14. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
[TBL] [Abstract][Full Text] [Related]
15. Single Domain Antibody Fragments as New Tools for the Detection of Neuronal Tau Protein in Cells and in Mice Studies.
Dupré E; Danis C; Arrial A; Hanoulle X; Homa M; Cantrelle FX; Merzougui H; Colin M; Rain JC; Buée L; Landrieu I
ACS Chem Neurosci; 2019 Sep; 10(9):3997-4006. PubMed ID: 31380615
[TBL] [Abstract][Full Text] [Related]
16. Expanding the Genetic Code for Neuronal Studies.
Nikić-Spiegel I
Chembiochem; 2020 Nov; 21(22):3169-3179. PubMed ID: 32531101
[TBL] [Abstract][Full Text] [Related]
17. [Cloning and expression of human single-chain Fv antibody against amyloid beta peptide involved in Alzheimer's disease].
Cai J; Wang SZ; Peng Y; Zhong YW; Ji ZJ; Yuan JG; Qiang BQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):557-62. PubMed ID: 14650158
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Alzheimer's beta-amyloid neurotoxicity by site-directed single-chain antibody.
Frenkel D; Solomon B; Benhar I
J Neuroimmunol; 2000 Jul; 106(1-2):23-31. PubMed ID: 10814779
[TBL] [Abstract][Full Text] [Related]
19. Separation of presenilin function in amyloid beta-peptide generation and endoproteolysis of Notch.
Kulic L; Walter J; Multhaup G; Teplow DB; Baumeister R; Romig H; Capell A; Steiner H; Haass C
Proc Natl Acad Sci U S A; 2000 May; 97(11):5913-8. PubMed ID: 10811883
[TBL] [Abstract][Full Text] [Related]
20. Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Abeta42 peptide.
Kim W; Hecht MH
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15824-9. PubMed ID: 17038501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
